ow-dose Atropine for the Prevention of Childhood Myopia Progression in Danish Children (APP-study) - The APP-study

Rigshospitalet0 个研究点目标入组 150 人开始时间: 2018年5月30日最近更新: 2024年7月8日

适应症

试验速览

暂无简介。

•Children aged =6-<9 years: myopia =-1 (spherical equivalent) in at least one eye
•Children aged =9-=12 years: myopia =-2 (spherical equivalent) in at least one eye
•Cylinder less than 1.5 diopters
•Are the trial subjects under 18? yes
•Number of subjects for this age range: 150
•F.1.2 Adults (18-64 years) no
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•Myopia related to retinal dystrophies
•Collagen syndroms (Ehlers-Danlos syndrome, Marfan syndrome and Stickler syndrome)
•Other ocular pathology (e.g., amblyopia, strabismus)
•Previous eye surgery
•Previous use of agents thought to affect myopia progression, e.g. atropine, pirenzepine or 7-methylxanthine (metabolite of caffeine and theobromine) and orthokeratology contact lenses
•Known allergy to atropine or any of the contents of the trial medication (active and in-active ingredients) used in the study
•Non-compliance to eye examinations
•Serious systemic health troubles (e.g., cardiac or respiratory illness) and developmental disorders and delays

发起方